Thyrocare Q4FY25 Revenue Up 21 Percent YoY to Rs 187.2 Cr; PAT Rises 24 Percent to Rs 21.3 Cr
Apr 25, 2025
Navi Mumbai (Maharashtra) [India], April 25: Thyrocare Technologies Limited (hereinafter referred to as "Thyrocare" NSE: THYROCARE, BSE: 539871), a leading healthcare diagnostics company, announces...